Research suggests that Cistanche and its active compounds may support energy metabolism and reduce fatigue, though the current evidence base is limited to animal studies, cell culture experiments, and theoretical review papers rather than human clinical trials. A mouse study found that a phenylethanoid-rich Cistanche extract extended physical endurance and improved blood markers related to muscle fatigue and energy availability, while a separate preclinical study found that acteoside, a compound isolated from Cistanche tubulosa, appeared to reduce cancer-related fatigue in mice by improving mitochondrial health through a specific cellular signaling pathway. A conceptual review paper also proposed that Cistanche may support mitochondrial energy production in a way that could be relevant to chronic fatigue syndrome, framing this through both traditional Chinese medicine theory and modern biology, though this paper reported no experimental results of its own. Studies indicate a consistently supportive directional trend across these findings, but the absence of human trials means it is not yet possible to draw conclusions about whether these effects translate to people, and the research should be considered preliminary.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A novel PHD2 inhibitor acteoside from Cistanche tubulosa induces skeletal mus... | Other | 2022 | Supports | 72 |
| Yang/Qi invigoration: an herbal therapy for chronic fatigue syndrome with yan... | Review | 2015 | Supports | 67 |
| Antifatigue activity of phenylethanoid-rich extract from Cistanche deserticola. | Other | 2010 | Supports | 62 |